Abstract
Introduction: Kidney transplantation is the most viable and cost-effective treatment option for patients with end-stage renal disease (ESRD). However, the limited availability of living donors opens up the option of utilizing deceased donor for kidney transplantation. Objectives: This study evaluated the long-term graft and recipient outcomes of deceased donor kidney transplantation (DDRT) in patients with ESRD. Patients and Methods: A retrospective analysis of ESRD patients who underwent DDRT (January 2002 to December 2018) was conducted. Transplant medical records were reviewed for the recipient’s demographic profile, causes of ESRD, type of transplants, type of induction treatment, and five-year follow-up data related to graft survival and mortality. Results: A total of 147 DDRT recipients with a mean age of 43.1 years were included. Male preponderance (66.67%) was observed. The common causes of ESRD were chronic glomerulonephritis (44.7%) and diabetic nephropathy (22.7%). Post-transplantation, patients were administered with induction therapy (anti-thymocyte globulin (ATG), 57.14%; basiliximab, 27.21%; and other induction agents, 15.65%). Patient survival rate at 1-year, 3-year and 5-year follow-up were 91%, 86% and 73%, respectively and graft survival rates were 89%, 79%, and 68%, respectively. Infection (87.07%) was the leading cause of death, followed by cardiovascular disease (11.56%). Conclusion: Long-term outcomes up to 5-years related to patient survival and graft survival in ESRD patients’ post-DDRT were satisfactory and suggested the use of DDRT as a replacement option for living donors.
Highlights
Kidney transplantation is the most viable and cost-effective treatment option for patients with end-stage renal disease (ESRD)
Implication for health policy/practice/research/medical education: In a study on 147 deceased donor renal transplantation recipients with a mean age of 43.1 years, we found, long-term outcomes of deceased donor renal transplantation in patients with end-stage renal disease were satisfactory and suggested the use of deceased donor renal transplantation as a replacement option for living donors
Between the available treatment modalities for ESRD patients, which include chronic dialysis and kidney transplantation, kidney transplantation has been proved to be associated with better survival rates, improved quality of life and cost-effectiveness [5,6,7]
Summary
Kidney transplantation is the most viable and cost-effective treatment option for patients with end-stage renal disease (ESRD). Objectives: This study evaluated the long-term graft and recipient outcomes of deceased donor kidney transplantation (DDRT) in patients with ESRD. Conclusion: Long-term outcomes up to 5-years related to patient survival and graft survival in ESRD patients’ post-DDRT were satisfactory and suggested the use of DDRT as a replacement option for living donors. In India, the deceased donor organ donation rate has increased from 0.08 to 0.34 per million population per year while renal transplantation using a living donor is more frequent than using deceased donor [8,9,10]. The only possible solution to bridge the increasing gap between the demand
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
